Durability of HBeAG seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

2003-03-01

Additional Metadata
Persistent URL	doi.org/10.1136/gut.52.3.420, hdl.handle.net/1765/54114
Journal	Gut (English Edition): an international journal of gastroenterology & hepatology
Organisation	Department of Gastroenterology & Hepatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Nunen, A. B., Hansen, B., Suh, D. J., Lohr, H. F., Chemello, L., Fontaine, H., … Schalm, S. (2003). Durability of HBeAG seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut (English Edition): an international journal of gastroenterology & hepatology, 52(3), 420–424. doi:10.1136/gut.52.3.420

Publication